TuHURA Biosciences, Inc.
NASDAQ: HURA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James A. Bianco
- Employees
- 19
- Headquarters
- Tampa, United States
- IPO year
- 2013
- Market cap
- $160.5M
- Website
- http://www.tuhurabio.com
Loading HURA…
Loading profile data…Frequently asked questions about HURA
What does TuHURA Biosciences, Inc. (HURA) do?
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Ta...
Where does HURA trade?
TuHURA Biosciences, Inc. (HURA) trades on the NASDAQ Capital Market.
What sector is HURA in?
TuHURA Biosciences, Inc. (HURA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TuHURA Biosciences, Inc.?
James A. Bianco is the chief executive officer of TuHURA Biosciences, Inc. (HURA).
Where is TuHURA Biosciences, Inc. headquartered?
TuHURA Biosciences, Inc. is headquartered in United States.
Does HURA pay a dividend?
TuHURA Biosciences, Inc. (HURA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HURA go public?
TuHURA Biosciences, Inc. (HURA) completed its initial public offering in 2013.